Detalhe da pesquisa
1.
Dapagliflozin Does Not Protect against Adriamycin-Induced Kidney Injury in Mice.
Kidney Blood Press Res
; 49(1): 81-90, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38185119
2.
Adaptive Nutrition Intervention Stabilizes Serum Phosphorus Levels in Hemodialysis Patients: A Multicenter Decentralized Clinical Trial Using Real-World Data.
J Ren Nutr
; 34(1): 47-57, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37586668
3.
Role of NADPH Oxidases in Renal Aging.
Gerontology
; 69(7): 852-865, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36709751
4.
APX-115, a first-in-class pan-NADPH oxidase (Nox) inhibitor, protects db/db mice from renal injury.
Lab Invest
; 97(4): 419-431, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28165467
5.
DA-1229, a dipeptidyl peptidase IV inhibitor, protects against renal injury by preventing podocyte damage in an animal model of progressive renal injury.
Lab Invest
; 96(5): 547-60, 2016 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-26878135
6.
Chronic Administration of Visfatin Ameliorated Diabetic Nephropathy in Type 2 Diabetic Mice.
Kidney Blood Press Res
; 41(3): 311-24, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27221663
7.
Renoprotective Effects of a Highly Selective A3 Adenosine Receptor Antagonist in a Mouse Model of Adriamycin-induced Nephropathy.
J Korean Med Sci
; 31(9): 1403-12, 2016 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-27510383
8.
Dipeptidyl peptidase IV inhibitor protects against renal interstitial fibrosis in a mouse model of ureteral obstruction.
Lab Invest
; 94(6): 598-607, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24687121
9.
Kidney Health Plan 2033 in Korea: bridging the gap between the present and the future.
Kidney Res Clin Pract
; 43(1): 8-19, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38311359
10.
Glucocorticoids attenuate septic acute kidney injury.
Biochem Biophys Res Commun
; 435(4): 678-84, 2013 Jun 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-23702481
11.
The Role of V-Set Ig Domain-Containing 4 in Chronic Kidney Disease Models.
Life (Basel)
; 13(2)2023 Jan 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-36836636
12.
Puromycin-induced kidney injury and subsequent regeneration in adult zebrafish.
Anim Cells Syst (Seoul)
; 27(1): 112-119, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37089626
13.
SH3YL1 Protein Predicts Renal Outcomes in Patients with Type 2 Diabetes.
Life (Basel)
; 13(4)2023 Apr 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37109492
14.
Pan-Nox inhibitor treatment improves renal function in aging murine diabetic kidneys.
Kidney Res Clin Pract
; 2023 Aug 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37559225
15.
Spexin-based galanin receptor 2 agonist improves renal injury in mice with type 2 diabetes.
Anim Cells Syst (Seoul)
; 27(1): 187-196, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37789932
16.
Adenosine receptors as emerging therapeutic targets for diabetic kidney disease.
Kidney Res Clin Pract
; 41(Suppl 2): S74-S88, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-36239063
17.
Upregulation of VSIG4 in Type 2 Diabetic Kidney Disease.
Life (Basel)
; 12(7)2022 Jul 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35888119
18.
Blood Pressure Control in Patients with Diabetic Kidney Disease.
Electrolyte Blood Press
; 20(2): 39-48, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36688208
19.
Aliskiren improves insulin resistance and ameliorates diabetic vascular complications in db/db mice.
Nephrol Dial Transplant
; 26(4): 1194-204, 2011 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-20921292
20.
Farnesoid X receptor (FXR) agonist ameliorates systemic insulin resistance, dysregulation of lipid metabolism, and alterations of various organs in a type 2 diabetic kidney animal model.
Acta Diabetol
; 58(4): 495-503, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33399988